Patents by Inventor Alberto Luini

Alberto Luini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reagents for optical microscopy
    Patent number: 11860099
    Abstract: An antibody or Fab fragment, wherein at least one amino group of the N-terminal amino acid of the light chain and/or of the N-terminal amino acid of the heavy chain is bound by an amidic bond to a molecule comprising a fluorophore group A, wherein said bond constitutes at least 70% of the total binding of said molecule to said antibody or Fab.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: January 2, 2024
    Assignee: Alda S.r.l.
    Inventors: Alberto Luini, Vincenzo Manuel Marzullo, Giuseppe Palumbo, Federica Liccardo
  • NEW REAGENTS FOR OPTICAL MICROSCOPY
    Publication number: 20200141869
    Abstract: An antibody or Fab fragment, wherein at least one amino group of the N-terminal amino acid of the light chain and/or of the N-terminal amino acid of the heavy chain is bound by an amidic bond to a molecule comprising a fluorophore group A, wherein said bond constitutes at least 70% of the total binding of said molecule to said antibody or Fab.
    Type: Application
    Filed: June 26, 2018
    Publication date: May 7, 2020
    Applicant: Alda S.r.l.
    Inventors: Alberto LUINI, Vincenzo Manuel MARZULLO, Giuseppe PALUMBO, Federica LICCARDO
  • KINASE AND UBIQUITIN LIGASE INHIBITORS AND USES THEREOF
    Publication number: 20200022957
    Abstract: A suppressor or inhibitor of expression and/or function of 4 a gene, a kinase or ubiquitin ligase, for use in the treatment of a protein conformational disorder is provided.
    Type: Application
    Filed: December 16, 2016
    Publication date: January 23, 2020
    Inventors: Alberto LUINI, Andrea Rosario BECCARI, Ramanath Narayana HEGDE, Seetaraman PARASHURAMAN
  • METHOD TO IDENTIFY COMPOUNDS ABLE TO BIND TO THE ROSSMANN FOLD OF C-TERMINAL-BINDING PROTEINS, IDENTIFIED COMPOUNDS AND MEDICAL USES THEREOF
    Publication number: 20170003275
    Abstract: The invention refers to a method for identifying an anti-tumoral and/or anti-proliferative and/or an inhibitor of the fission machinery involved in mitotic Golgi partitioning and/or a molecule modulator of CtBP corepressor activity by testing their affinity binding for the Rossmann fold of C-terminal-binding proteins (CtBPs); to said identified molecules and to the use thereof as anti-proliferative and/or anti tumoral agents.
    Type: Application
    Filed: May 16, 2014
    Publication date: January 5, 2017
    Inventors: Antonino COLANZI, Alberto LUINI, Daniela CORDA
  • Use of glycerophosphoinositols for the treatment of septic shock
    Patent number: 9351983
    Abstract: The present invention refers to glycerophosphoinositols (GPIs) and derivatives thereof for use in the treatment of pathologies related to a Lipopolysaccharide (LPS)-activated tissue-factor (TF) activity, as pathologies induced by high bacteremia, i.e. septic shock.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: May 31, 2016
    Assignee: CONSIGLIO NAZIONALE DELLE RICERCHE
    Inventors: Daniela Corda, Pasquale Zizza, Alberto Luini, Stefania Mariggio'
  • USE OF GLYCEROPHOSPHOINOSITOLS FOR THE TREATMENT OF SEPTIC SHOCK
    Publication number: 20150272971
    Abstract: The present invention refers to glycerophosphoinositols (GPIs) and derivatives thereof for use in the treatment of pathologies related to a Lipopolysaccharide (LPS)-activated tissue-factor (TF) activity, as pathologies induced by high bacteremia, i.e. septic shock.
    Type: Application
    Filed: October 4, 2013
    Publication date: October 1, 2015
    Inventors: Daniela Corda, Pasquale Zizza, Alberto Luini, Stefania Mariggio'